Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diagnostics
Nir Diagnostics Amends Stock Option Plan
July 22nd, 2007
NIR Diagnostics Inc. (TSX Venture: NID), a leading-edge developer of near-infrared medical instruments, today announced that at its Annual and Special Meeting of Shareholders held on June 28, 2007, shareholders approved amendments to the Company's 2003 Stock Option Plan (the "Plan"). The amendments included an increase in the number of shares reserved for issuance under the Plan from 4,750,000 to 6,750,000. The amendments are subject to regulatory approval. Also today, the Company announced grants of stock options to five independent directors of the Company. At a meeting on June 28, 2007, the Board of Directors of NIR Diagnostics Inc. granted such independent directors...
Source: Medical Devices & Surgical Technology Week (2007-07-22)
|
